DEEPIKA PAKIANATHAN - 27 Jan 2023 Form 4 Insider Report for Calithera Biosciences, Inc.

Role
Director
Signature
/s/ Matthew T. Potter, Attorney-in-Fact for Deepika Pakianathan
Issuer symbol
CALA on OTC
Transactions as of
27 Jan 2023
Net transactions value
-$46,810
Form type
4
Filing time
31 Jan 2023, 18:04:07 UTC
Previous filing
10 Jun 2022
Next filing
04 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CALA Common Stock Sale $46,358 -120,161 -100% $0.3858 0 27 Jan 2023 Delphi Ventures VIII, L.P. F1, F2
transaction CALA Common Stock Sale $452 -1,172 -100% $0.3858 0 27 Jan 2023 Delphi BioInvestments VIII, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.36 to $0.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F2 The reported securities were directly held by Delphi Ventures VIII, L.P. ("DV VIII"). Delphi Management Partners VIII, L.L.C. ("DMP VIII") is the general partner of DV VIII and was deemed to have sole voting and dispositive power over the securities held by DV VIII. Douglas A. Roeder, James J. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of DMP VIII and were deemed to share voting and dispositive power over the securities held by DV VIII. Such persons and entities disclaim beneficial ownership of the securities held by DV VIII, except to the extent of any pecuniary interest therein.
F3 The reported securities were directly held by Delphi BioInvestments VIII, L.P. ("DBI VIII"). DMP VIII is the general partner of DBI VIII and was deemed to have sole voting and dispositive power over the securities held by DBI VIII. Douglas A. Roeder, James J. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of DMP VIII and were deemed to share voting and dispositive power over the securities held by DBI VIII. Such persons and entities disclaim beneficial ownership of the securities held by DBI VIII, except to the extent of any pecuniary interest therein.